OneSource Specialty Pharma received USFDA EIR with VAI classification for Bengaluru SPD facility. Inspection conducted from June 22 to June 30, 2026, concluded with voluntary action indicated status. Facility supports sterile injectables within OneSource. [OneSource Specialty Pharma Limited](https://scanx.trade/company/onesource-specialty-pharma-ltd) received an Establishment Inspection Report (EIR) with a **Voluntary Action Indicated** (VAI) classification from the U.S. Food and Drug Administration (USFDA) for its Sterile Product Division (SPD) facility in Bengaluru.